HRP20020231A2
(en)
*
|
2002-03-18 |
2003-12-31 |
Pliva D D |
ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
|
US5912331A
(en)
*
|
1991-03-15 |
1999-06-15 |
Merck & Co., Inc. |
Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
|
US5985844A
(en)
*
|
1992-03-26 |
1999-11-16 |
Merck & Co., Inc. |
Homoerythromycin A derivatives modified at the 4"-and 8A-positions
|
US5189159A
(en)
*
|
1992-04-02 |
1993-02-23 |
Merck & Co., Inc. |
8a-AZA-8a-homoerythromycin cyclic iminoethers
|
EP0539223A1
(en)
*
|
1991-10-25 |
1993-04-28 |
Ono Pharmaceutical Co., Ltd. |
Glycine derivative monosodium salt tetrahydrate having an inhibitory effect on elastase
|
US5215980A
(en)
*
|
1992-01-17 |
1993-06-01 |
Merck & Co., Inc. |
10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
|
US5210235A
(en)
*
|
1992-08-26 |
1993-05-11 |
Merck & Co., Inc. |
Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
|
US5332807A
(en)
*
|
1993-04-14 |
1994-07-26 |
Merck & Co., Inc. |
Process of producing 8A- and 9A-azalide antibiotics
|
CN1034734C
(zh)
*
|
1993-12-10 |
1997-04-30 |
北京市集才药物研究所 |
一种新的阿齐红霉素结晶及其制备方法
|
US5605889A
(en)
|
1994-04-29 |
1997-02-25 |
Pfizer Inc. |
Method of administering azithromycin
|
SK282854B6
(sk)
|
1994-05-06 |
2002-12-03 |
Pfizer Inc. |
Dávkovacia forma s riadeným uvoľňovaním obsahujúca azitromycín
|
ES2122905B1
(es)
*
|
1996-07-11 |
1999-11-16 |
Astur Pharma Sa |
Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
|
AU755315B2
(en)
*
|
1997-10-16 |
2002-12-12 |
Pliva-Istrazivacki Institut D.O.O. |
Novel 3,6-hemiketals from the class of 9a-azalides
|
US6861411B1
(en)
|
1997-12-02 |
2005-03-01 |
Pfizer, Inc. |
Method of treating eye infections with azithromycin
|
PT102130A
(pt)
*
|
1998-03-13 |
1999-09-30 |
Hovione Sociedade Quimica S A |
Processo de preparacao de dihidrato de azitromicina
|
TW546302B
(en)
*
|
1998-05-08 |
2003-08-11 |
Biochemie Sa |
Improvements in macrolide production
|
CA2245398C
(en)
*
|
1998-08-21 |
2002-01-29 |
Apotex Inc. |
Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
|
HK1043725B
(en)
|
1998-11-30 |
2005-05-06 |
Teva Pharmaceutical Industries Ltd. |
Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
US7056893B2
(en)
|
1999-03-31 |
2006-06-06 |
Insite Vision, Inc. |
Topical treatment for prevention of ocular infections
|
MXPA01011914A
(es)
*
|
1999-05-18 |
2002-05-06 |
Pfizer Prod Inc |
Nuevas formas cristalinas de un antibiotico macrolido.
|
ATE469910T1
(de)
*
|
1999-06-29 |
2010-06-15 |
Sandoz Ag |
Azithromycinmonohydrat
|
ES2177373B1
(es)
*
|
1999-11-26 |
2003-11-01 |
Astur Pharma Sa |
Preparacion de azitromicina en su forma no cristalina
|
PT1246831E
(pt)
*
|
2000-01-04 |
2008-03-28 |
Teva Pharma |
Método de preparação de di-hidrato de azitromicina
|
ES2162764B1
(es)
*
|
2000-05-17 |
2003-04-01 |
Ercros Ind Sa |
Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
|
EP1304326B1
(en)
|
2000-07-25 |
2006-03-15 |
Laboratorio Silanes, S.A. de C.V. |
Single-step process for preparing 7,16-deoxy-2-aza-10-o-cladinosil-12-o-desosaminil-4,5-dihydroxi-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1)hexadeca-1(2)-en-8-ona and obtaining a new form of 9-desoxo-9a-methyl-9a-aza-9a-homoerythromycin a
|
ES2172417B1
(es)
*
|
2000-07-31 |
2003-09-16 |
Sint Quimica Sa |
Nueva forma mejorada de azitromicina monohidrato de menor higroscopicidad, procedimiento de preparacion y composiciones farmaceuticas que la comprenden.
|
JP2004506664A
(ja)
|
2000-08-23 |
2004-03-04 |
ウォックハート・リミテッド |
無水アジトロマイシンの製造法
|
SK287814B6
(sk)
*
|
2000-11-27 |
2011-11-04 |
Sandoz Ag |
Azithromycin in the form of a monohydrate, a process for its preparation and pharmaceutical compositions comprising same
|
UA76967C2
(uk)
*
|
2000-11-27 |
2006-10-16 |
Сандоз Аг |
Азитроміцин у формі моногідрату, фармацевтична композиція та спосіб його одержання
|
IN190080B
(forum.php)
*
|
2001-01-29 |
2003-06-07 |
Alembic Ltd |
|
KR100491183B1
(ko)
|
2001-03-21 |
2005-05-25 |
한미약품 주식회사 |
아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
|
ATE319730T1
(de)
*
|
2001-05-22 |
2006-03-15 |
Pfizer Prod Inc |
Neue kristallforme von azithromycin
|
US6861413B2
(en)
|
2001-05-22 |
2005-03-01 |
Pfizer Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
EP1671978A1
(en)
|
2001-05-22 |
2006-06-21 |
Pfizer Products Inc. |
New Cristal Form of Azithromycin
|
YU8804A
(sh)
*
|
2001-08-21 |
2006-08-17 |
Pfizer Products Inc. |
Jedno-dozni azitromicin
|
AU2002348884A1
(en)
|
2001-12-21 |
2003-07-09 |
Pfizer Products Inc. |
Directly compressible formulations of azithromycin
|
CA2470055A1
(en)
*
|
2001-12-21 |
2003-07-03 |
Pfizer Products Inc. |
Methods for wet granulating azithromycin
|
MXPA04007427A
(es)
*
|
2002-02-01 |
2004-10-11 |
Pfizer Prod Inc |
Formulaciones de azitromicina granuladas por via seca.
|
US7376064B2
(en)
|
2002-02-25 |
2008-05-20 |
Samsung Electronics Co., Ltd. |
Method and apparatus for recording data on optical recording medium
|
ITMI20021209A1
(it)
*
|
2002-06-04 |
2003-12-04 |
Chemi Spa |
Processo di preparazione di azitromicina ad elevata purezza
|
US6855813B2
(en)
*
|
2002-07-19 |
2005-02-15 |
Alembic Limited |
Process for the preparation of azithromycin monohydrate
|
HRP20020614A2
(en)
|
2002-07-22 |
2004-06-30 |
PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. |
Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
|
GB2395482A
(en)
*
|
2003-07-03 |
2004-05-26 |
Jubilant Organosys Ltd |
Process for preparing non-hygroscopic azithromycin dihydrate
|
US20050013835A1
(en)
*
|
2003-07-15 |
2005-01-20 |
Pfizer Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
ES2600577T3
(es)
*
|
2003-12-04 |
2017-02-09 |
Bend Research, Inc. |
Procedimiento de pulverización-solidificación que usa un extrusor para preparar composiciones en multipartículas de fármacos cristalinos
|
BRPI0416535A
(pt)
*
|
2003-12-04 |
2007-01-09 |
Pfizer Prod Inc |
processo de congelamento por vaporização empregando um extrusor para preparar composições de azitromicina de multiparticulado contendo preferivelmente um poloxámero e um glicerìdeo
|
WO2005053652A1
(en)
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
|
US6984403B2
(en)
*
|
2003-12-04 |
2006-01-10 |
Pfizer Inc. |
Azithromycin dosage forms with reduced side effects
|
CA2547239A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Azithromycin multiparticulate dosage forms by liquid-based processes
|
JP2007513139A
(ja)
*
|
2003-12-04 |
2007-05-24 |
ファイザー・プロダクツ・インク |
安定性の改善した多粒子組成物
|
CN1889932A
(zh)
*
|
2003-12-04 |
2007-01-03 |
辉瑞产品公司 |
制备药用多颗粒的方法
|
WO2005053639A2
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Controlled release multiparticulates formed with dissolution enhancers
|
RU2260012C1
(ru)
*
|
2004-01-29 |
2005-09-10 |
Открытое акционерное общество "Акционерное курганское общество медицинских препаратов и изделий "Синтез" |
Способ кристаллизации азитромицина дигидрата
|
US20060116336A1
(en)
*
|
2004-03-17 |
2006-06-01 |
American Pharmaceutical Partners, Inc. |
Lyophilized azithromycin formulation
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
WO2006011160A1
(en)
|
2004-06-28 |
2006-02-02 |
Alembic Limited |
Process for the preparation of azithromycin monohydrate isopropanol clathrate
|
CN1308361C
(zh)
*
|
2004-08-09 |
2007-04-04 |
大连振邦氟涂料股份有限公司 |
乙烯-三氟氯乙烯共聚物的制备方法
|
US7683162B2
(en)
*
|
2004-08-30 |
2010-03-23 |
Taro Pharmaceutical Industries Limited |
Process of preparing a crystalline azithromycin monohydrate
|
JP2007523896A
(ja)
*
|
2004-12-01 |
2007-08-23 |
テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ |
アスコマイシンの結晶形態とその調製方法
|
JP2008524317A
(ja)
*
|
2004-12-21 |
2008-07-10 |
ファイザー・プロダクツ・インク |
腸溶コーティングされたアジスロマイシン多粒子
|
US8524735B2
(en)
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
CN100366686C
(zh)
*
|
2006-01-12 |
2008-02-06 |
济南瑞氟化工科技有限公司 |
一种氟硅超双疏不粘涂料
|
US20070281894A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted erythromycin analogs
|
US7704959B2
(en)
|
2006-10-03 |
2010-04-27 |
Dow Pharmaceutical Sciences |
Azithromycin for the treatment of nodular acne
|
US20090062220A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched azithromycin
|
CN101177441B
(zh)
*
|
2007-12-05 |
2012-05-23 |
浙江耐司康药业有限公司 |
一种稳定的阿奇霉素一水合物结晶的制备方法
|
CN101624412B
(zh)
*
|
2008-07-10 |
2012-07-04 |
刘力 |
大环内酯类衍生物及其制备和用途
|
NZ719761A
(en)
|
2008-10-07 |
2017-11-24 |
Raptor Pharmaceuticals Inc |
Aerosol fluoroquinolone formulations for improved pharmacokinetics
|
CA2739893C
(en)
|
2008-10-07 |
2016-10-04 |
Mpex Pharmaceuticals, Inc. |
Inhalation of levofloxacin for reducing lung inflammation
|
CN101418026B
(zh)
*
|
2008-10-09 |
2011-05-18 |
南京工业大学 |
一种晶型和粒度可控的阿奇霉素结晶工艺
|
CN101787063B
(zh)
*
|
2009-01-23 |
2012-12-19 |
刘力 |
抗感染药物及其制备和用途
|
AU2010223233A1
(en)
|
2009-03-13 |
2011-10-06 |
Assistance Publique - Hopitaux De Paris |
Compositions and methods for elimination of Gram-negative bacteria
|
HRP20191408T1
(hr)
|
2009-09-04 |
2019-11-15 |
Horizon Orphan Llc |
Uporaba aerosol levofloksacin otopine za liječenje cistične fibroze
|
CN102911219A
(zh)
*
|
2011-08-03 |
2013-02-06 |
山东方明药业集团股份有限公司 |
一种阿齐霉素在水相直接结晶的方法
|
CN103159811A
(zh)
*
|
2011-12-10 |
2013-06-19 |
山东方明药业集团股份有限公司 |
一种阿齐霉素中间体9a-脱氧-9a-氮杂-9a-高红霉素A的制备方法
|
WO2013088274A1
(en)
|
2011-12-14 |
2013-06-20 |
Wockhardt Limited |
Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
|
CN102417531B
(zh)
*
|
2011-12-20 |
2014-06-11 |
浙江国邦药业有限公司 |
一种阿奇霉素一水合物的制备方法
|